Scholay

学术搜索 · AI 审稿 · LaTeX 协作

VP4-2023: Sotorasib 960 mg versus 240 mg in pretreated KRAS G12C advanced NSCLC

作者:Maximilian J. Hochmair, Karim Vermaelen, G. Mountzios, Enric Carcereny, Christophe Dooms, SH Lee, Éva Mórocz, Terufumi Kato, T-E. Ciuleanu, Grace K. Dy, Márcio Parente, Kenneth J. O’Byrne, Q.S-C. Chu, Gilberto de Castro, Nicolas Girard, Wendy Snyder, Qui Tran, William Kormany, Brett E. Houk, Alessandra Curioni‐Fontecedro · 发表于:Annals of Oncology · 年份:2023 · DOI:10.1016/j.annonc.2023.10.790 · 被引用次数:13 · 研究领域:Chronic Lymphocytic Leukemia Research、Chronic Myeloid Leukemia Treatments、Colorectal Cancer Treatments and Studies